QR kód

Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics

Introduction: Australia has provided unrestricted subsidized access to direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection since 2016. Epidemiological surveillance estimates suggest prevalence of chronic HCV infection has declined since 2016, but these estimates are not sep...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hossain M.S. Sazzad, Hui Li, Behzad Hajarizadeh, Bethany A. Horsburgh, Jason Grebely, Gregory J. Dore, Rowena A. Bull, Andrew R. Lloyd, Chaturaka Rodrigo
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2025-05-01
Edice:Virus Research
Témata:
On-line přístup:http://www.sciencedirect.com/science/article/pii/S0168170225000437
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!